Release Date: 31/10/13 08:48 Summary: Quarterly Cashflow Report Price Sensitive: Yes Download Document 37.38KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%